
L-Dopa 98%
Levodopa is commonly Extract from the seeds of Mucuna cochinchinesis,
a leguminous plant used to treat Parkinson's disease.
Levodopa
CAS number 59-92-7
Molecular weight 197.188
Density 1.5±0.1 g/cm3
Boiling point 448.4±45.0 °C at 760 mmHg
Molecular Formula C9H11NO4
Melting point 276-278 °C(lit.)
Flash point 225.0±28.7 °C

Product Name | MucunaPruriens Extract |
Batch Number |
N-F-ZX015 |
Latin Name | Stizolobium capitatum | Package | 25kg/Drum |
Plant Part Used | Mucuna(100% Natural) | Origin | China |
CAS number | 59-92-7 | Molecular Weight | 197.188 |
Molecular Formula | C9H11NO4 | Extract Ratio | 30:1 |
Herbal Strength | Levodopa | Extraction | Alcohol |
Quality Standard | Meet CP & USP and home standard |
Function of Levodopa
1.Treatment of Parkinson's disease:
Levodopa is the most basic and effective drug for the treatment of Parkinson's disease,
and it has a good curative effect on tremor, rigidity, bradykinesia, etc.
2.Improve muscle tone:
Levodopa tablets usually have the efficacy and effect of improving muscle tone, and are generally used in patients with Parkinson's disease.
After use, it can relieve uncomfortable symptoms such as tremors and slow movement caused by Parkinson's disease.
3.Treatment of Parkinson's syndrome:
The effect of levodopa therapy may not be particularly significant for Parkinson's syndrome, but in the case of Parkinson's disease,
supplementation with levodopa drugs is often required to achieve some improvement.
4.Treatment of heart failure:
Studies have shown that levodopa can be used to treat heart failure, and good results have been obtained in clinical trials.
5.Treatment of peptic ulcers:
Levodopa is also used to treat patients with peptic ulcer disease and has shown positive results in clinical application.
6.Treatment of galactorrhea:
Levodopa inhibits hypothalamic thyrotropin releasing hormone, thereby reducing prolactin secretion and limiting galactorrhea .
7.Treatment of neuromuscular disorders:
Levodopa has also shown potential in the treatment of certain neuromuscular disorders.
8.Treatment of amblyopia in children/adolescents:
Levodopa tablets are currently officially approved by the SFDA(China Food and Drug Administration) for the treatment of amblyopia in children.
